11. Fabrication and installation of the Mu2e cryogenic distribution system. Issue 1 (1st May 2022) Authors: White, M; Lamm, M; Hocker, A; Arnold, D; Tatkowski, G; Kilmer, J; Poloubotko, V; Tope, T; Huang, Y; Elementi, L; Badgley, K; Voirin, E; Young, I; Brandt, J; Feher, S; Hess, C; Markley, D Journal: IOP conference series Issue: Volume 1240:Issue 1(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
12. GRB 191016A: a highly collimated gamma-ray burst jet with magnetized energy injection. Issue 4 (24th November 2021) Authors: Shrestha, M; Steele, I A; Kobayashi, S; Jordana-Mitjans, N; Smith, R J; Jermak, H; Arnold, D; Mundell, C G; Gomboc, A; Guidorzi, C Journal: Monthly notices of the Royal Astronomical Society Issue: Volume 509:Issue 4(2022) Page Start: 5964 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
13. Health-related quality of life in patients with a germline BRCA mutation and metastatic pancreatic cancer receiving maintenance olaparib. (28th September 2019) Authors: Hammel, P; Kindler, H L; Reni, M; Van Cutsem, E; Macarulla, T; Hall, M J; Park, J O; Hochhauser, D; Arnold, D; Oh, D -Y; Reinacher-Schick, A; Tortora, G; Algül, H; O'Reilly, E M; McGuinness, D; Cui, K Y; Joo, S; Yoo, H K; Patel, N; Golan, T Journal: Annals of oncology Issue: Volume 30:Number 12(2019) Page Start: 1959 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
14. Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (31st January 2019) Authors: Vogel, A; Cervantes, A; Chau, I; Daniele, B; Llovet, J M; Meyer, T; Nault, J -C; Neumann, U; Ricke, J; Sangro, B; Schirmacher, P; Verslype, C; Zech, C J; Arnold, D; Martinelli, E Journal: Annals of oncology Issue: Volume 30:Number 5(2019) Page Start: 871 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
15. Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (3rd October 2018) Authors: Vogel, A; Cervantes, A; Chau, I; Daniele, B; Llovet, J; Meyer, T; Nault, J -C; Neumann, U; Ricke, J; Sangro, B; Schirmacher, P; Verslype, C; Zech, C J; Arnold, D; Martinelli, E Journal: Annals of oncology Issue: Volume 29(2018)Supplement 4 Page Start: iv238 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
16. Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (3rd October 2018) Authors: Vogel, A; Cervantes, A; Chau, I; Daniele, B; Llovet, J M; Meyer, T; Nault, J -C; Neumann, U; Ricke, J; Sangro, B; Schirmacher, P; Verslype, C; Zech, C J; Arnold, D; Martinelli, E Journal: Annals of oncology Issue: Volume 29(2018)Supplement 4 Page Start: iv238 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
17. Impact of age on the efficacy of oxaliplatin in the preoperative chemoradiotherapy and adjuvant chemotherapy of rectal cancer: a post hoc analysis of the CAO/ARO/AIO-04 phase III trial. (4th June 2018) Authors: Hofheinz, R -D; Arnold, D; Fokas, E; Kaufmann, M; Hothorn, T; Folprecht, G; Fietkau, R; Hohenberger, W; Ghadimi, M; Liersch, T; Grabenbauer, G G; Sauer, R; Rödel, C; Graeven, U Journal: Annals of oncology Issue: Volume 29:Number 8(2018) Page Start: 1793 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
18. LBA-001Olaparib as maintenance treatment following first-line platinum-based chemotherapy in patients with a germline BRCA mutation and metastatic pancreatic cancer: phase III POLO trial. (2nd July 2019) Authors: Golan, T; Hammel, P; Reni, M; Van Cutsem, E; Macarulla, T; Hall, M; Park, J; Hochhauser, D; Arnold, D; Oh, D; Reinacher-Schick, A; Tortora, G; Algül, H; O'Reilly, E; McGuinness, D; Cui, K; Schlienger, K; Locker, G; Kindler, H Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
19. LBA19Fluoropyrimidine (FP) + bevacizumab (BEV) + atezolizumab vs FP/BEV in BRAFwt metastatic colorectal cancer (mCRC): Findings from Cohort 2 of MODUL – a multicentre, randomized trial of biomarker-driven maintenance treatment following first-line induction therapy. (23rd October 2018) Authors: Grothey, A; Tabernero, J; Arnold, D; De Gramont, A; Ducreux, M P; O'Dwyer, P J; Van Cutsem, E; Bosanac, I; Srock, S; Mancao, C; Gilberg, F; Winter, J; Schmoll, H-J Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
20. LBA21InterAACT: A multicentre open label randomised phase II advanced anal cancer trial of cisplatin (CDDP) plus 5-fluorouracil (5-FU) vs carboplatin (C) plus weekly paclitaxel (P) in patients (pts) with inoperable locally recurrent (ILR) or metastatic treatment naïve disease - An International Rare Cancers Initiative (IRCI) trial. (23rd October 2018) Authors: Rao, S; Sclafani, F; Eng, C; Grønlie Guren, M; Adams, R A; Benson, A; Sebag-Montefiore, D; Segelov, E; Bryant, A; Peckitt, C; Roy, A; Seymour, M T; Welch, J; Saunders, M P; Muirhead, R; Bridgewater, J; Falk, S; Glynne-Jones, R; Arnold, D; Cunningham, D Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗